Aythya fuligula isolate bAytFul2 chromosome 9, bAytFul2.pri, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Anseriformes; Anatidae; Aythyinae; Aythya.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020308.1.\nAssembly name: bAytFul2.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2019/12/31. The original whole-genome shotgun project has the\naccession WNMM00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2019\nAssembly Method :: FALCON v. 2018.31.08-03.06; FALCON-Unzip\n v. 6.0.0.47841; purge_haplotigs v.\n v1.0.3+ 1.Nov.2018; scaff10x v. 4.1.0;\n Bionano Solve DLS v. 3.2.1; Salsa HiC v.\n 2.2; Arrow smrtanalysis Pacbio polishing\n & gap filling v. 6.0.0.47841; longranger\n align v. 2.2.2; freebayes Illumina\n polishing v. 1.3; gEVAL manual curation\n v. 2019-09-20; VGP assembly pipeline\n individual v. 1.5\nAssembly Name :: bAytFul2.pri\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 64.03x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Aythya fuligula Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.3\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Patrik Ellstrom, Mahmoud Naguib, Josef Jarhult
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC116492585, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC116492585, transcript variant X2
uncharacterized LOC116492585, transcript variant X1
uncharacterized LOC116492585, transcript variant X3
phosphatidylinositol glycan anchor biosynthesis class Z
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear cap-binding protein subunit 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nuclear cap-binding protein subunit 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
angiotensin II receptor type 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
angiotensin II receptor type 1, transcript variant X3
angiotensin II receptor type 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
angiotensin II receptor type 1, transcript variant X2
angiotensin II receptor type 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC116492437, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC116492437, transcript variant X8
uncharacterized LOC116492437, transcript variant X9
uncharacterized LOC116492437, transcript variant X6
uncharacterized LOC116492437, transcript variant X10
uncharacterized LOC116492437, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC116492437, transcript variant X7
uncharacterized LOC116492437, transcript variant X1
uncharacterized LOC116492437, transcript variant X4
uncharacterized LOC116492437, transcript variant X3
uncharacterized LOC116492437, transcript variant X11
uncharacterized protein LOC116492437 isoform X2
uncharacterized protein LOC116492437 isoform X6
uncharacterized protein LOC116492437 isoform X4
uncharacterized protein LOC116492437 isoform X3
uncharacterized protein LOC116492437 isoform X5
uncharacterized protein LOC116492437 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Zic family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Zic family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Zic family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
phospholipid scramblase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid scramblase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid scramblase 1, transcript variant X3
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 isoform X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 isoform X1
very low-density lipoprotein receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: very low-density lipoprotein receptor-like
electron transfer flavoprotein subunit alpha, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: divergent protein kinase domain 2A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium/hydrogen exchanger 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
U2 snRNP associated SURP domain containing
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: U2 snRNP-associated SURP motif-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
progestin and adipoQ receptor family member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transient receptor potential cation channel subfamily C member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel subfamily C member 1, transcript variant X1
short transient receptor potential channel 1 isoform X2
short transient receptor potential channel 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 7 bases in 6 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 7 bases in 6 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/threonine-protein kinase ATR
5'-3' exoribonuclease 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5'-3' exoribonuclease 1, transcript variant X6
5'-3' exoribonuclease 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5'-3' exoribonuclease 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5'-3' exoribonuclease 1, transcript variant X3
5'-3' exoribonuclease 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor Dp-2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor Dp-2, transcript variant X2
transcription factor Dp-2, transcript variant X1
transcription factor Dp-2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor Dp-2, transcript variant X8
transcription factor Dp-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcription factor Dp-2, transcript variant X5
transcription factor Dp-2, transcript variant X4
ATPase Na+/K+ transporting subunit beta 3, transcript variant X2
ATPase Na+/K+ transporting subunit beta 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-3 isoform X2
sodium/potassium-transporting ATPase subunit beta-3 isoform X1
G protein-coupled receptor kinase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
G protein-coupled receptor kinase 7, transcript variant X1
ring finger protein 7, transcript variant X1
ring finger protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
RAS p21 protein activator 2, transcript variant X2
RAS p21 protein activator 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAS p21 protein activator 2, transcript variant X1
RAS p21 protein activator 2, transcript variant X3
RAS p21 protein activator 2, transcript variant X5
ras GTPase-activating protein 2 isoform X1
ras GTPase-activating protein 2 isoform X2
ras GTPase-activating protein 2 isoform X3
zinc finger and BTB domain containing 38, transcript variant X2
zinc finger and BTB domain containing 38, transcript variant X6
zinc finger and BTB domain containing 38, transcript variant X1
zinc finger and BTB domain containing 38, transcript variant X7
zinc finger and BTB domain containing 38, transcript variant X4
zinc finger and BTB domain containing 38, transcript variant X3
zinc finger and BTB domain containing 38, transcript variant X5
zinc finger and BTB domain-containing protein 38
solute carrier family 16 member 14, transcript variant X3
solute carrier family 16 member 14, transcript variant X1
solute carrier family 16 member 14, transcript variant X4
solute carrier family 16 member 14, transcript variant X2
monocarboxylate transporter 14 isoform X1
monocarboxylate transporter 14 isoform X2
thyroid hormone receptor interactor 12, transcript variant X4
thyroid hormone receptor interactor 12, transcript variant X1
thyroid hormone receptor interactor 12, transcript variant X3
thyroid hormone receptor interactor 12, transcript variant X5
thyroid hormone receptor interactor 12, transcript variant X2
E3 ubiquitin-protein ligase TRIP12 isoform X1
E3 ubiquitin-protein ligase TRIP12 isoform X2
E3 ubiquitin-protein ligase TRIP12 isoform X3
E3 ubiquitin-protein ligase TRIP12 isoform X4
delta and Notch-like epidermal growth factor-related receptor
phosphotyrosine interaction domain containing 1, transcript variant X1
PTB-containing, cubilin and LRP1-interacting protein isoform X1
phosphotyrosine interaction domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PTB-containing, cubilin and LRP1-interacting protein isoform X2
SPHK1 interactor, AKAP domain containing, transcript variant X1
SPHK1 interactor, AKAP domain containing, transcript variant X3
SPHK1 interactor, AKAP domain containing, transcript variant X2
A-kinase anchor protein SPHKAP isoform X1
A-kinase anchor protein SPHKAP isoform X3
A-kinase anchor protein SPHKAP isoform X2
dynein assembly factor with WD repeats 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
dynein assembly factor with WDR repeat domains 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
ArfGAP with FG repeats 1, transcript variant X6
ArfGAP with FG repeats 1, transcript variant X5
ArfGAP with FG repeats 1, transcript variant X4
ArfGAP with FG repeats 1, transcript variant X3
ArfGAP with FG repeats 1, transcript variant X2
ArfGAP with FG repeats 1, transcript variant X1
arf-GAP domain and FG repeat-containing protein 1 isoform X6
arf-GAP domain and FG repeat-containing protein 1 isoform X5
arf-GAP domain and FG repeat-containing protein 1 isoform X4
arf-GAP domain and FG repeat-containing protein 1 isoform X3
arf-GAP domain and FG repeat-containing protein 1 isoform X2
arf-GAP domain and FG repeat-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
39S ribosomal protein L44, mitochondrial
mitochondrial fission factor, transcript variant X2
mitochondrial fission factor, transcript variant X3
mitochondrial fission factor, transcript variant X8
mitochondrial fission factor, transcript variant X7
mitochondrial fission factor, transcript variant X5
mitochondrial fission factor, transcript variant X4
mitochondrial fission factor, transcript variant X6
mitochondrial fission factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 isoform X2
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2, transcript variant X2
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2, transcript variant X3
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2, transcript variant X1
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 isoform X1
dedicator of cytokinesis 10, transcript variant X9
dedicator of cytokinesis 10, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis protein 10 isoform X15
dedicator of cytokinesis protein 10 isoform X9
dedicator of cytokinesis 10, transcript variant X11
dedicator of cytokinesis 10, transcript variant X12
dedicator of cytokinesis protein 10 isoform X11
dedicator of cytokinesis protein 10 isoform X12
dedicator of cytokinesis 10, transcript variant X1
dedicator of cytokinesis 10, transcript variant X6
dedicator of cytokinesis 10, transcript variant X13
dedicator of cytokinesis 10, transcript variant X5
dedicator of cytokinesis 10, transcript variant X7
dedicator of cytokinesis 10, transcript variant X3
dedicator of cytokinesis 10, transcript variant X2
dedicator of cytokinesis 10, transcript variant X4
dedicator of cytokinesis 10, transcript variant X8
dedicator of cytokinesis 10, transcript variant X14
dedicator of cytokinesis protein 10 isoform X6
dedicator of cytokinesis protein 10 isoform X8
dedicator of cytokinesis protein 10 isoform X1
dedicator of cytokinesis protein 10 isoform X4
dedicator of cytokinesis protein 10 isoform X13
dedicator of cytokinesis protein 10 isoform X14
dedicator of cytokinesis protein 10 isoform X5
dedicator of cytokinesis protein 10 isoform X7
dedicator of cytokinesis protein 10 isoform X3
dedicator of cytokinesis protein 10 isoform X2
dedicator of cytokinesis 10, transcript variant X10
dedicator of cytokinesis 10, transcript variant X16
dedicator of cytokinesis protein 10 isoform X16
dedicator of cytokinesis protein 10 isoform X10
putative coiled-coil domain-containing protein 195
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 17% coverage of the annotated genomic feature by RNAseq alignments
guanylate cyclase soluble subunit beta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 124 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serpin family E member 2, transcript variant X2
serpin family E member 2, transcript variant X1
serpin family E member 2, transcript variant X3
WD repeat and FYVE domain containing 1, transcript variant X1
WD repeat and FYVE domain-containing protein 1 isoform X1
WD repeat and FYVE domain containing 1, transcript variant X2
WD repeat and FYVE domain-containing protein 1 isoform X2
adaptor related protein complex 1 subunit sigma 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily E regulatory subunit 4
potassium voltage-gated channel subfamily E member 4
acyl-CoA synthetase long chain family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
phenylalanyl-tRNA synthetase subunit beta, transcript variant X1
phenylalanyl-tRNA synthetase subunit beta, transcript variant X2
phenylalanyl-tRNA synthetase subunit beta, transcript variant X4
phenylalanyl-tRNA synthetase subunit beta, transcript variant X3
phenylalanine--tRNA ligase beta subunit isoform X1
phenylalanine--tRNA ligase beta subunit isoform X2
phenylalanine--tRNA ligase beta subunit isoform X4
phenylalanine--tRNA ligase beta subunit isoform X3
sphingosine-1-phosphate phosphatase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sphingosine-1-phosphate phosphatase 2, transcript variant X2
sphingosine-1-phosphate phosphatase 2 isoform X1
sphingosine-1-phosphate phosphatase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
2-phosphoxylose phosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
2-phosphoxylose phosphatase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
2-phosphoxylose phosphatase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
2-phosphoxylose phosphatase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
2-phosphoxylose phosphatase 1 isoform X2
2-phosphoxylose phosphatase 1 isoform X1
splA/ryanodine receptor domain and SOCS box containing 4, transcript variant X2
splA/ryanodine receptor domain and SOCS box containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 4, transcript variant X3
SPRY domain-containing SOCS box protein 4 isoform X2
SPRY domain-containing SOCS box protein 4 isoform X1
SPRY domain-containing SOCS box protein 4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
nicotinamide nucleotide adenylyltransferase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
28S ribosomal protein S22, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta, transcript variant X3
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta, transcript variant X1
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta, transcript variant X2
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta, transcript variant X4
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
vesicle-associated membrane protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
integral membrane protein 2C, transcript variant X1
integral membrane protein 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G-protein coupled receptor 35-like, transcript variant X1
G-protein coupled receptor 35-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G-protein coupled receptor 35-like isoform X1
G-protein coupled receptor 35-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
ST6 beta-galactoside alpha-2,6-sialyltransferase 1, transcript variant X1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1, transcript variant X4
ST6 beta-galactoside alpha-2,6-sialyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ST6 beta-galactoside alpha-2,6-sialyltransferase 1, transcript variant X2
ST6 beta-galactoside alpha-2,6-sialyltransferase 1, transcript variant X5
beta-galactoside alpha-2,6-sialyltransferase 1
adiponectin, C1Q and collagen domain containing
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-glucose glycoprotein glucosyltransferase 1, transcript variant X2
UDP-glucose glycoprotein glucosyltransferase 1, transcript variant X1
UDP-glucose:glycoprotein glucosyltransferase 1 isoform X2
UDP-glucose:glycoprotein glucosyltransferase 1 isoform X1
Sin3A associated protein 130, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Sin3A associated protein 130, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone deacetylase complex subunit SAP130 isoform X1
histone deacetylase complex subunit SAP130 isoform X2
DNA-directed RNA polymerase II subunit RPB4
WD repeat domain 33, transcript variant X1
WD repeat domain 33, transcript variant X2
WD repeat domain 33, transcript variant X4
WD repeat domain 33, transcript variant X5
WD repeat domain 33, transcript variant X3
WD repeat domain 33, transcript variant X7
WD repeat domain 33, transcript variant X8
WD repeat domain 33, transcript variant X6
pre-mRNA 3' end processing protein WDR33 isoform X1
pre-mRNA 3' end processing protein WDR33 isoform X2
pre-mRNA 3' end processing protein WDR33 isoform X4
pre-mRNA 3' end processing protein WDR33 isoform X3
pre-mRNA 3' end processing protein WDR33 isoform X5
pre-mRNA 3' end processing protein WDR33 isoform X7
pre-mRNA 3' end processing protein WDR33 isoform X8
pre-mRNA 3' end processing protein WDR33 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LIM zinc finger domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM zinc finger domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LIM zinc finger domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LIM and senescent cell antigen-like-containing domain protein 2 isoform X1
LIM zinc finger domain containing 2, transcript variant X3
LIM zinc finger domain containing 2, transcript variant X2
LIM and senescent cell antigen-like-containing domain protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uracil nucleotide/cysteinyl leukotriene receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
interacts with SUPT6H, CTD assembly factor 1, transcript variant X1
interacts with SUPT6H, CTD assembly factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
diacylglycerol kinase delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
diacylglycerol kinase delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
autophagy related 16 like 1, transcript variant X4
autophagy related 16 like 1, transcript variant X2
autophagy related 16 like 1, transcript variant X3
autophagy related 16 like 1, transcript variant X1
autophagy-related protein 16-1 isoform X4
autophagy-related protein 16-1 isoform X2
autophagy-related protein 16-1 isoform X3
autophagy-related protein 16-1 isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00478
inositol polyphosphate-5-phosphatase D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inositol polyphosphate-5-phosphatase D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 isoform X2
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuronal guanine nucleotide exchange factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
secondary ossification center associated regulator of chondrocyte maturation, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
secondary ossification center associated regulator of chondrocyte maturation, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GRB10 interacting GYF protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GRB10 interacting GYF protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GRB10 interacting GYF protein 2, transcript variant X3
GRB10 interacting GYF protein 2, transcript variant X1
GRB10-interacting GYF protein 2 isoform X4
GRB10-interacting GYF protein 2 isoform X2
GRB10-interacting GYF protein 2 isoform X3
GRB10-interacting GYF protein 2 isoform X1
potassium inwardly rectifying channel subfamily J member 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC116492547, transcript variant X1
uncharacterized LOC116492547, transcript variant X2
solute carrier family 35 member G2, transcript variant X1
solute carrier family 35 member G2, transcript variant X2
solute carrier family 35 member G2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
stromal antigen 1, transcript variant X5
stromal antigen 1, transcript variant X6
stromal antigen 1, transcript variant X1
stromal antigen 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
stromal antigen 1, transcript variant X2
stromal antigen 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
propionyl-CoA carboxylase beta chain, mitochondrial
protein phosphatase 2 regulatory subunit B''alpha, transcript variant X1
serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform X1
protein phosphatase 2 regulatory subunit B''alpha, transcript variant X2
serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
armadillo repeat containing 8, transcript variant X2
armadillo repeat containing 8, transcript variant X1
armadillo repeat-containing protein 8 isoform X1
armadillo repeat-containing protein 8 isoform X2
armadillo repeat containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
armadillo repeat-containing protein 8 isoform X3
VPS8 subunit of CORVET complex, transcript variant X1
VPS8 subunit of CORVET complex, transcript variant X2
vacuolar protein sorting-associated protein 8 homolog isoform X1
vacuolar protein sorting-associated protein 8 homolog isoform X2
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
mitogen-activated protein kinase kinase kinase 13, transcript variant X1
mitogen-activated protein kinase kinase kinase 13, transcript variant X2
mitogen-activated protein kinase kinase kinase 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
centrosomal protein 63, transcript variant X2
centrosomal protein 63, transcript variant X1
centrosomal protein 63, transcript variant X6
centrosomal protein 63, transcript variant X4
centrosomal protein 63, transcript variant X5
anaphase promoting complex subunit 13, transcript variant X1
anaphase promoting complex subunit 13, transcript variant X2
centrosomal protein 63, transcript variant X3
centrosomal protein of 63 kDa isoform X1
centrosomal protein of 63 kDa isoform X4
centrosomal protein of 63 kDa isoform X2
centrosomal protein of 63 kDa isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DAZ interacting zinc finger protein 1 like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 8% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein DZIP1L
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member B11
ATP-dependent 6-phosphofructokinase, liver type
cilia and flagella associated protein 410
cilia- and flagella-associated protein 410
insulin like growth factor 2 mRNA binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
insulin-like growth factor 2 mRNA-binding protein 2 isoform X1
insulin like growth factor 2 mRNA binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
insulin-like growth factor 2 mRNA-binding protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
solute carrier organic anion transporter family member 2A1, transcript variant X2
solute carrier organic anion transporter family member 2A1, transcript variant X1
solute carrier organic anion transporter family member 2A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class X
phosphatidylinositol-glycan biosynthesis class X protein
centrosomal protein 19, transcript variant X1
centrosomal protein 19, transcript variant X2
centrosomal protein 19, transcript variant X3
negative regulator of reactive oxygen species
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
transforming growth factor beta activator LRRC33
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
WD repeat domain 53, transcript variant X2
WD repeat domain 53, transcript variant X1
WD repeat-containing protein 53 isoform X1
WD repeat-containing protein 53 isoform X2
ring finger protein 168, transcript variant X1
ring finger protein 168, transcript variant X2
UBX domain protein 7, transcript variant X1
UBX domain-containing protein 7 isoform X1
UBX domain protein 7, transcript variant X2
UBX domain-containing protein 7 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: galactose-3-O-sulfotransferase 2
D-2-hydroxyglutarate dehydrogenase, mitochondrial
THAP domain containing 4, transcript variant X1
THAP domain-containing protein 4 isoform X1
THAP domain containing 4, transcript variant X2
THAP domain-containing protein 4 isoform X2
ILK associated serine/threonine phosphatase, transcript variant X2
ILK associated serine/threonine phosphatase, transcript variant X1
integrin-linked kinase-associated serine/threonine phosphatase 2C isoform X2
integrin-linked kinase-associated serine/threonine phosphatase 2C isoform X1
kinesin family member 1A, transcript variant X12
kinesin family member 1A, transcript variant X9
kinesin family member 1A, transcript variant X8
kinesin family member 1A, transcript variant X4
kinesin family member 1A, transcript variant X6
kinesin family member 1A, transcript variant X5
kinesin family member 1A, transcript variant X3
kinesin family member 1A, transcript variant X2
kinesin family member 1A, transcript variant X1
kinesin family member 1A, transcript variant X19
kinesin family member 1A, transcript variant X13
kinesin family member 1A, transcript variant X20
kinesin family member 1A, transcript variant X18
kinesin family member 1A, transcript variant X11
kinesin family member 1A, transcript variant X10
kinesin family member 1A, transcript variant X7
kinesin family member 1A, transcript variant X14
kinesin family member 1A, transcript variant X17
kinesin family member 1A, transcript variant X16
kinesin family member 1A, transcript variant X15
alanine--glyoxylate and serine--pyruvate aminotransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
LOW QUALITY PROTEIN: protein mab-21-like 4
sushi, nidogen and EGF-like domain-containing protein 1
mitochondrial transcription termination factor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
transcription termination factor 4, mitochondrial
PAS domain containing serine/threonine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
PAS domain-containing serine/threonine-protein kinase
protein phosphatase 1 regulatory subunit 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 7 isoform X2
protein phosphatase 1 regulatory subunit 7, transcript variant X1
protein phosphatase 1 regulatory subunit 7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
high density lipoprotein binding protein, transcript variant X1
high density lipoprotein binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X1
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X2
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X3
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X4
FERM, ARH/RhoGEF and pleckstrin domain protein 2, transcript variant X5
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X1
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X2
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X3
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X4
FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X5
BCL2 family apoptosis regulator BOK, transcript variant X1
BCL2 family apoptosis regulator BOK, transcript variant X2
bcl-2-related ovarian killer protein isoform X1
bcl-2-related ovarian killer protein isoform X2
ETS variant transcription factor 5, transcript variant X2
ETS variant transcription factor 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
diacylglycerol kinase beta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
diacylglycerol kinase beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
diacylglycerol kinase beta-like isoform X2
diacylglycerol kinase beta-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
pituitary tumor-transforming gene 1 protein-interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
thrombospondin type laminin G domain and EAR repeats
thrombospondin-type laminin G domain and EAR repeat-containing protein
transient receptor potential cation channel subfamily M member 2, transcript variant X1
transient receptor potential cation channel subfamily M member 2, transcript variant X2
transient receptor potential cation channel subfamily M member 2 isoform X1
transient receptor potential cation channel subfamily M member 2 isoform X2
G2/M phase-specific E3 ubiquitin-protein ligase-like
pleckstrin homology domain containing B2, transcript variant X4
pleckstrin homology domain containing B2, transcript variant X1
pleckstrin homology domain containing B2, transcript variant X3
pleckstrin homology domain containing B2, transcript variant X2
pleckstrin homology domain-containing family B member 2
family with sequence similarity 168 member B, transcript variant X2
family with sequence similarity 168 member B, transcript variant X1
myelin-associated neurite-outgrowth inhibitor
Rho guanine nucleotide exchange factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho guanine nucleotide exchange factor 4 isoform X1
rho guanine nucleotide exchange factor 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
kelch like family member 24, transcript variant X1
kelch like family member 24, transcript variant X2
YEATS domain containing 2, transcript variant X1
YEATS domain containing 2, transcript variant X3
YEATS domain containing 2, transcript variant X4
YEATS domain containing 2, transcript variant X5
YEATS domain containing 2, transcript variant X2
YEATS domain-containing protein 2 isoform X1
YEATS domain-containing protein 2 isoform X2
YEATS domain-containing protein 2 isoform X3
YEATS domain-containing protein 2 isoform X4
MAP6 domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
MAP6 domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
presenilins-associated rhomboid-like protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
discs large MAGUK scaffold protein 1, transcript variant X2
discs large MAGUK scaffold protein 1, transcript variant X1
discs large MAGUK scaffold protein 1, transcript variant X3
discs large MAGUK scaffold protein 1, transcript variant X8
discs large MAGUK scaffold protein 1, transcript variant X5
discs large MAGUK scaffold protein 1, transcript variant X4
discs large MAGUK scaffold protein 1, transcript variant X6
discs large MAGUK scaffold protein 1, transcript variant X7
discs large MAGUK scaffold protein 1, transcript variant X10
discs large MAGUK scaffold protein 1, transcript variant X13
discs large MAGUK scaffold protein 1, transcript variant X12
discs large MAGUK scaffold protein 1, transcript variant X15
discs large MAGUK scaffold protein 1, transcript variant X14
discs large MAGUK scaffold protein 1, transcript variant X9
discs large MAGUK scaffold protein 1, transcript variant X16
discs large MAGUK scaffold protein 1, transcript variant X11
discs large MAGUK scaffold protein 1, transcript variant X17
discs large MAGUK scaffold protein 1, transcript variant X18
discs large MAGUK scaffold protein 1, transcript variant X19
discs large MAGUK scaffold protein 1, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
discs large MAGUK scaffold protein 1, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
discs large MAGUK scaffold protein 1, transcript variant X20
discs large MAGUK scaffold protein 1, transcript variant X21
D-beta-hydroxybutyrate dehydrogenase, mitochondrial
D-beta-hydroxybutyrate dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 2, transcript variant X2
protein phosphatase 1 regulatory inhibitor subunit 2, transcript variant X3
protein phosphatase 1 regulatory inhibitor subunit 2, transcript variant X1
protein phosphatase inhibitor 2 isoform X2
protein phosphatase inhibitor 2 isoform X3
protein phosphatase inhibitor 2 isoform X1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2, transcript variant X1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2, transcript variant X3
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2, transcript variant X2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2, transcript variant X4
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X4
family with sequence similarity 43 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
large 60S subunit nuclear export GTPase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cation-transporting ATPase 13A3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing protein 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: transcription factor HES-1
OPA1 mitochondrial dynamin like GTPase, transcript variant X3
OPA1 mitochondrial dynamin like GTPase, transcript variant X1
OPA1 mitochondrial dynamin like GTPase, transcript variant X4
OPA1 mitochondrial dynamin like GTPase, transcript variant X2
dynamin-like 120 kDa protein, mitochondrial isoform X4
dynamin-like 120 kDa protein, mitochondrial isoform X2
dynamin-like 120 kDa protein, mitochondrial isoform X3
dynamin-like 120 kDa protein, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
probable cation-transporting ATPase 13A4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
probable cation-transporting ATPase 13A5
phospholipase A and acyltransferase 1, transcript variant X2
phospholipase A and acyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 12, transcript variant X4
fibroblast growth factor 12, transcript variant X3
fibroblast growth factor 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain-containing protein 50
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
geminin coiled-coil domain-containing protein 1
interleukin 1 receptor accessory protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
interleukin-1 receptor accessory protein isoform X1
interleukin 1 receptor accessory protein, transcript variant X2
interleukin-1 receptor accessory protein isoform X2
interleukin 1 receptor accessory protein, transcript variant X3
interleukin-1 receptor accessory protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tumor protein p63, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
tumor protein p63, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
LIM domain containing preferred translocation partner in lipoma
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cytoskeleton-associated protein 5-like
mannan binding lectin serine peptidase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Tctex1 domain containing 2, transcript variant X2
Tctex1 domain containing 2, transcript variant X1
phosphate cytidylyltransferase 1, choline, alpha, transcript variant X1
phosphate cytidylyltransferase 1, choline, alpha, transcript variant X2
choline-phosphate cytidylyltransferase A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
organic solute transporter subunit alpha
transferrin receptor, transcript variant X3
transferrin receptor, transcript variant X2
transferrin receptor, transcript variant X1
transferrin receptor, transcript variant X4
transferrin receptor protein 1 isoform X1
transferrin receptor protein 1 isoform X2
tyrosine kinase non receptor 2, transcript variant X4
tyrosine kinase non receptor 2, transcript variant X5
tyrosine kinase non receptor 2, transcript variant X2
tyrosine kinase non receptor 2, transcript variant X1
tyrosine kinase non receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
rubicon autophagy regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rubicon autophagy regulator, transcript variant X3
rubicon autophagy regulator, transcript variant X1
rubicon autophagy regulator, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X2
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X3
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X1
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X4
forty-two-three domain containing 1, transcript variant X1
forty-two-three domain containing 1, transcript variant X2
leucine rich repeats and calponin homology domain containing 3, transcript variant X1
leucine rich repeats and calponin homology domain containing 3, transcript variant X2
leucine rich repeats and calponin homology domain containing 3, transcript variant X11
leucine rich repeats and calponin homology domain containing 3, transcript variant X10
leucine rich repeats and calponin homology domain containing 3, transcript variant X15
leucine rich repeats and calponin homology domain containing 3, transcript variant X13
leucine rich repeats and calponin homology domain containing 3, transcript variant X6
leucine rich repeats and calponin homology domain containing 3, transcript variant X3
leucine rich repeats and calponin homology domain containing 3, transcript variant X7
leucine rich repeats and calponin homology domain containing 3, transcript variant X9
leucine rich repeats and calponin homology domain containing 3, transcript variant X14
leucine rich repeats and calponin homology domain containing 3, transcript variant X5
leucine rich repeats and calponin homology domain containing 3, transcript variant X8
leucine rich repeats and calponin homology domain containing 3, transcript variant X12
leucine rich repeats and calponin homology domain containing 3, transcript variant X4
IQ motif containing G, transcript variant X2
IQ motif containing G, transcript variant X3
IQ motif containing G, transcript variant X1
dynein regulatory complex protein 9 isoform X2
dynein regulatory complex protein 9 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
armadillo repeat containing 9, transcript variant X1
armadillo repeat containing 9, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
COORDINATES: nucleotide motif:Rfam:12.0:RF00217
COORDINATES: nucleotide motif:Rfam:12.0:RF00158
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
prothymosin alpha, transcript variant X1
prothymosin alpha, transcript variant X3
prothymosin alpha, transcript variant X2
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
intestinal-type alkaline phosphatase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
cholinergic receptor nicotinic delta subunit
cholinergic receptor nicotinic gamma subunit
eukaryotic translation initiation factor 4E family member 2, transcript variant X2
eukaryotic translation initiation factor 4E family member 2, transcript variant X1
eukaryotic translation initiation factor 4E type 2 isoform X2
eukaryotic translation initiation factor 4E type 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP binding cassette subfamily C member 5, transcript variant X2
ATP binding cassette subfamily C member 5, transcript variant X1
multidrug resistance-associated protein 5 isoform X2
multidrug resistance-associated protein 5 isoform X1
ATP binding cassette subfamily C member 5, transcript variant X4
ATP binding cassette subfamily C member 5, transcript variant X3
multidrug resistance-associated protein 5 isoform X4
multidrug resistance-associated protein 5 isoform X3
eukaryotic translation initiation factor 2B subunit epsilon
translation initiation factor eIF-2B subunit epsilon
dishevelled segment polarity protein 3, transcript variant X1
dishevelled segment polarity protein 3, transcript variant X3
dishevelled segment polarity protein 3, transcript variant X2
dishevelled segment polarity protein 3, transcript variant X4
segment polarity protein dishevelled homolog DVL-3 isoform X1
segment polarity protein dishevelled homolog DVL-3 isoform X3
segment polarity protein dishevelled homolog DVL-3 isoform X2
segment polarity protein dishevelled homolog DVL-3 isoform X4
dishevelled segment polarity protein 3, transcript variant X5
segment polarity protein dishevelled homolog DVL-3 isoform X5
adaptor related protein complex 2 subunit mu 1, transcript variant X1
adaptor related protein complex 2 subunit mu 1, transcript variant X4
adaptor related protein complex 2 subunit mu 1, transcript variant X3
adaptor related protein complex 2 subunit mu 1, transcript variant X2
adaptor related protein complex 2 subunit mu 1, transcript variant X5
adaptor related protein complex 2 subunit mu 1, transcript variant X6
ATP binding cassette subfamily F member 3
ATP-binding cassette sub-family F member 3
prophage side tail fiber protein homolog StfR-like, transcript variant X3
prophage side tail fiber protein homolog StfR-like, transcript variant X4
prophage side tail fiber protein homolog StfR-like, transcript variant X2
prophage side tail fiber protein homolog StfR-like, transcript variant X1
prophage side tail fiber protein homolog StfR-like
von Willebrand factor A domain containing 5B2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
von Willebrand factor A domain-containing protein 5B2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: EEF1A lysine methyltransferase 4
calcium/calmodulin dependent protein kinase II inhibitor 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: calcium/calmodulin-dependent protein kinase II inhibitor 2
mitochondrial ubiquitin ligase activator of nfkb 1-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
endothelin converting enzyme 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
endothelin-converting enzyme 2 isoform X1
endothelin converting enzyme 2, transcript variant X2
endothelin-converting enzyme 2 isoform X2
proteasome 26S subunit, non-ATPase 2, transcript variant X2
proteasome 26S subunit, non-ATPase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 2
eukaryotic translation initiation factor 4 gamma 1, transcript variant X1
eukaryotic translation initiation factor 4 gamma 1, transcript variant X2
eukaryotic translation initiation factor 4 gamma 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00572
family with sequence similarity 131 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
chloride voltage-gated channel 2, transcript variant X1
chloride voltage-gated channel 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 31% coverage of the annotated genomic feature by RNAseq alignments
DNA-directed RNA polymerases I, II, and III subunit RPABC3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SUMO specific peptidase 5, transcript variant X2
SUMO specific peptidase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4A2
COORDINATES: nucleotide motif:Rfam:12.0:RF01299
COORDINATES: nucleotide motif:Rfam:12.0:RF01241
COORDINATES: nucleotide motif:Rfam:12.0:RF00092
MCF.2 cell line derived transforming sequence-like 2, transcript variant X4
MCF.2 cell line derived transforming sequence-like 2, transcript variant X3
probable guanine nucleotide exchange factor MCF2L2 isoform X3
probable guanine nucleotide exchange factor MCF2L2 isoform X4
MCF.2 cell line derived transforming sequence-like 2, transcript variant X6
MCF.2 cell line derived transforming sequence-like 2, transcript variant X1
MCF.2 cell line derived transforming sequence-like 2, transcript variant X5
MCF.2 cell line derived transforming sequence-like 2, transcript variant X2
MCF.2 cell line derived transforming sequence-like 2, transcript variant X7
MCF.2 cell line derived transforming sequence-like 2, transcript variant X9
MCF.2 cell line derived transforming sequence-like 2, transcript variant X10
probable guanine nucleotide exchange factor MCF2L2 isoform X1
probable guanine nucleotide exchange factor MCF2L2 isoform X5
probable guanine nucleotide exchange factor MCF2L2 isoform X7
probable guanine nucleotide exchange factor MCF2L2 isoform X9
probable guanine nucleotide exchange factor MCF2L2 isoform X10
probable guanine nucleotide exchange factor MCF2L2 isoform X2
probable guanine nucleotide exchange factor MCF2L2 isoform X6
MCF.2 cell line derived transforming sequence-like 2, transcript variant X8
probable guanine nucleotide exchange factor MCF2L2 isoform X8
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X6
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X5
lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
lysosome-associated membrane glycoprotein 3
methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial
defective in cullin neddylation 1 domain containing 1
ATPase phospholipid transporting 11B (putative), transcript variant X10
ATPase phospholipid transporting 11B (putative), transcript variant X9
ATPase phospholipid transporting 11B (putative), transcript variant X7
probable phospholipid-transporting ATPase IF isoform X7
ATPase phospholipid transporting 11B (putative), transcript variant X4
ATPase phospholipid transporting 11B (putative), transcript variant X2
probable phospholipid-transporting ATPase IF isoform X4
probable phospholipid-transporting ATPase IF isoform X2
ATPase phospholipid transporting 11B (putative), transcript variant X3
ATPase phospholipid transporting 11B (putative), transcript variant X11
ATPase phospholipid transporting 11B (putative), transcript variant X1
ATPase phospholipid transporting 11B (putative), transcript variant X5
ATPase phospholipid transporting 11B (putative), transcript variant X6
probable phospholipid-transporting ATPase IF isoform X8
probable phospholipid-transporting ATPase IF isoform X3
probable phospholipid-transporting ATPase IF isoform X1
probable phospholipid-transporting ATPase IF isoform X5
ATPase phospholipid transporting 11B (putative), transcript variant X8
probable phospholipid-transporting ATPase IF isoform X6
uncharacterized LOC116492701, transcript variant X2
uncharacterized LOC116492701, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C19, transcript variant X2
DnaJ heat shock protein family (Hsp40) member C19, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM14
FMR1 autosomal homolog 1, transcript variant X2
FMR1 autosomal homolog 1, transcript variant X1
FMR1 autosomal homolog 1, transcript variant X3
fragile X mental retardation syndrome-related protein 1 isoform X2
fragile X mental retardation syndrome-related protein 1 isoform X3
fragile X mental retardation syndrome-related protein 1 isoform X1
coiled-coil domain containing 39, transcript variant X1
coiled-coil domain containing 39, transcript variant X2
coiled-coil domain-containing protein 39 isoform X1
coiled-coil domain-containing protein 39 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
peroxisomal biogenesis factor 5 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
peroxisomal biogenesis factor 5 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
peroxisomal biogenesis factor 5 like, transcript variant X7
peroxisomal biogenesis factor 5 like, transcript variant X5
peroxisomal biogenesis factor 5 like, transcript variant X1
peroxisomal biogenesis factor 5 like, transcript variant X3
peroxisomal biogenesis factor 5 like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 13
NADH:ubiquinone oxidoreductase subunit B5
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial
39S ribosomal protein L47, mitochondrial
G protein subunit beta 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G protein subunit beta 4, transcript variant X4
G protein subunit beta 4, transcript variant X3
G protein subunit beta 4, transcript variant X2
guanine nucleotide-binding protein subunit beta-4
zinc finger protein 639, transcript variant X4
zinc finger protein 639, transcript variant X1
zinc finger protein 639, transcript variant X3
zinc finger protein 639, transcript variant X2
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, transcript variant X1
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
potassium calcium-activated channel subfamily M regulatory beta subunit 2, transcript variant X2
potassium calcium-activated channel subfamily M regulatory beta subunit 2, transcript variant X1
potassium calcium-activated channel subfamily M regulatory beta subunit 2, transcript variant X3
calcium-activated potassium channel subunit beta-2 isoform X2
calcium-activated potassium channel subunit beta-2 isoform X1
calcium-activated potassium channel subunit beta-2 isoform X3
F-box-like/WD repeat-containing protein TBL1XR1
N-acetylated alpha-linked acidic dipeptidase like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2
epithelial cell transforming 2, transcript variant X2
epithelial cell transforming 2, transcript variant X1
TNF superfamily member 10, transcript variant X1
TNF superfamily member 10, transcript variant X2
TNF superfamily member 10, transcript variant X3
tumor necrosis factor ligand superfamily member 10 isoform X1
tumor necrosis factor ligand superfamily member 10 isoform X2
tumor necrosis factor ligand superfamily member 10 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
growth hormone secretagogue receptor type 1
fibronectin type III domain containing 3B
fibronectin type III domain-containing protein 3B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane protein 212
TRAF2 and NCK interacting kinase, transcript variant X1
TRAF2 and NCK interacting kinase, transcript variant X2
TRAF2 and NCK interacting kinase, transcript variant X3
TRAF2 and NCK interacting kinase, transcript variant X4
TRAF2 and NCK-interacting protein kinase isoform X1
TRAF2 and NCK-interacting protein kinase isoform X2
TRAF2 and NCK-interacting protein kinase isoform X3
TRAF2 and NCK-interacting protein kinase isoform X4
TRAF2 and NCK interacting kinase, transcript variant X5
TRAF2 and NCK-interacting protein kinase isoform X5
solute carrier family 2 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 2, facilitated glucose transporter member 2 isoform X2
solute carrier family 2 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 2, facilitated glucose transporter member 2 isoform X1
eukaryotic translation initiation factor 5A2
eukaryotic translation initiation factor 5A-2
probable cationic amino acid transporter
polyhomeotic homolog 3, transcript variant X1
polyhomeotic homolog 3, transcript variant X2
polyhomeotic homolog 3, transcript variant X3
polyhomeotic homolog 3, transcript variant X4
SEC62 homolog, preprotein translocation factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sterile alpha motif domain-containing protein 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 31
leucine rich repeats and IQ motif containing 4
leucine-rich repeat and IQ domain-containing protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 34
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
MDS1 and EVI1 complex locus, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
MDS1 and EVI1 complex locus, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
MDS1 and EVI1 complex locus, transcript variant X4
MDS1 and EVI1 complex locus, transcript variant X1
histone-lysine N-methyltransferase MECOM isoform X2
histone-lysine N-methyltransferase MECOM isoform X1
histone-lysine N-methyltransferase MECOM isoform X3
histone-lysine N-methyltransferase MECOM isoform X4
multiple epidermal growth factor-like domains protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
golgi integral membrane protein 4, transcript variant X2
golgi integral membrane protein 4, transcript variant X1
Golgi integral membrane protein 4 isoform X1
Golgi integral membrane protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
zinc finger B-box domain-containing protein 1
butyrylcholinesterase, transcript variant X3
butyrylcholinesterase, transcript variant X1
butyrylcholinesterase, transcript variant X2
SLIT and NTRK like family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SLIT and NTRK like family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SLIT and NTRK like family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SLIT and NTRK like family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SLIT and NTRK like family member 3, transcript variant X4
SLIT and NTRK like family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC116492730, transcript variant X2
uncharacterized LOC116492730, transcript variant X1
uncharacterized LOC116492731, transcript variant X2
uncharacterized LOC116492731, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
serine palmitoyltransferase small subunit B, transcript variant X2
serine palmitoyltransferase small subunit B, transcript variant X1
serine palmitoyltransferase small subunit B
serine palmitoyltransferase small subunit B-like
protein phosphatase, Mg2+/Mn2+ dependent 1L
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X2
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X3
UDP-GalNAc:beta-1, 3-N-acetylgalactosaminyltransferase 1 isoform X1
UDP-GalNAc:beta-1, 3-N-acetylgalactosaminyltransferase 1 isoform X2
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF01295
structural maintenance of chromosomes 4, transcript variant X4
structural maintenance of chromosomes 4, transcript variant X2
structural maintenance of chromosomes 4, transcript variant X5
structural maintenance of chromosomes 4, transcript variant X3
structural maintenance of chromosomes 4, transcript variant X1
structural maintenance of chromosomes protein 4
intraflagellar transport 80, transcript variant X2
intraflagellar transport 80, transcript variant X1
intraflagellar transport protein 80 homolog
caspase recruitment domain family member 8, transcript variant X2
caspase recruitment domain family member 8, transcript variant X4
caspase recruitment domain-containing protein 8 isoform X2
caspase recruitment domain family member 8, transcript variant X3
caspase recruitment domain family member 8, transcript variant X5
caspase recruitment domain family member 8, transcript variant X6
caspase recruitment domain-containing protein 8 isoform X3
caspase recruitment domain family member 8, transcript variant X1
caspase recruitment domain-containing protein 8 isoform X1
schwannomin-interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
schwannomin-interacting protein 1, transcript variant X2
schwannomin-interacting protein 1, transcript variant X4
schwannomin-interacting protein 1, transcript variant X3
IQCJ-SCHIP1 readthrough transcript protein isoform X2
IQCJ-SCHIP1 readthrough transcript protein isoform X1
schwannomin-interacting protein 1 isoform X4
schwannomin-interacting protein 1 isoform X3
major facilitator superfamily domain containing 1, transcript variant X1
major facilitator superfamily domain-containing protein 1 isoform X1
major facilitator superfamily domain containing 1, transcript variant X2
major facilitator superfamily domain-containing protein 1 isoform X2
major facilitator superfamily domain containing 1, transcript variant X3
major facilitator superfamily domain-containing protein 1 isoform X3
retinoic acid receptor responder protein 1
myeloid leukemia factor 1, transcript variant X2
myeloid leukemia factor 1, transcript variant X1
myeloid leukemia factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 66 member 1 like, transcript variant X1
putative uncharacterized protein SLC66A1L
solute carrier family 66 member 1 like, transcript variant X2
ventricular zone expressed PH domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ventricular zone-expressed PH domain-containing protein homolog 1
leucine, glutamate and lysine rich 1, transcript variant X2
leucine, glutamate and lysine rich 1, transcript variant X1
leucine, glutamate and lysine rich 1, transcript variant X3
leucine-, glutamate- and lysine-rich protein 1 isoform X2
leucine-, glutamate- and lysine-rich protein 1 isoform X1
leucine-, glutamate- and lysine-rich protein 1 isoform X3
leucine, glutamate and lysine rich 1, transcript variant X4
leucine-, glutamate- and lysine-rich protein 1 isoform X4
TCDD inducible poly(ADP-ribose) polymerase, transcript variant X1
TCDD inducible poly(ADP-ribose) polymerase, transcript variant X2
protein mono-ADP-ribosyltransferase TIPARP
translocon-associated protein subunit gamma
potassium voltage-gated channel subfamily A member regulatory beta subunit 1
voltage-gated potassium channel subunit beta-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipase C eta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipase C eta 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipase C eta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 isoform X3
small transmembrane regulator of ion transport 1
sarcoplasmic/endoplasmic reticulum calcium ATPase regulator DWORF
membrane metalloendopeptidase, transcript variant X3
membrane metalloendopeptidase, transcript variant X2
membrane metalloendopeptidase, transcript variant X1
membrane metalloendopeptidase, transcript variant X4
DEAH-box helicase 36, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DEAH-box helicase 36, transcript variant X1
Rho guanine nucleotide exchange factor 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
purinergic receptor P2Y1, transcript variant X2
purinergic receptor P2Y1, transcript variant X1
muscleblind like splicing regulator 1, transcript variant X5
muscleblind like splicing regulator 1, transcript variant X3
muscleblind like splicing regulator 1, transcript variant X6
muscleblind like splicing regulator 1, transcript variant X4
muscleblind like splicing regulator 1, transcript variant X1
muscleblind like splicing regulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
arylacetamide deacetylase, transcript variant X2
arylacetamide deacetylase, transcript variant X3
arylacetamide deacetylase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mediator complex subunit 12L, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mediator of RNA polymerase II transcription subunit 12-like protein isoform X5
immunoglobulin superfamily member 10, transcript variant X1
immunoglobulin superfamily member 10 isoform X1
immunoglobulin superfamily member 10, transcript variant X2
immunoglobulin superfamily member 10, transcript variant X4
immunoglobulin superfamily member 10, transcript variant X3
immunoglobulin superfamily member 10, transcript variant X5
immunoglobulin superfamily member 10 isoform X2
mediator complex subunit 12L, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mediator complex subunit 12L, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mediator complex subunit 12L, transcript variant X7
mediator complex subunit 12L, transcript variant X2
mediator complex subunit 12L, transcript variant X4
mediator complex subunit 12L, transcript variant X1
mediator complex subunit 12L, transcript variant X3
mediator of RNA polymerase II transcription subunit 12-like protein isoform X8
mediator of RNA polymerase II transcription subunit 12-like protein isoform X6
mediator of RNA polymerase II transcription subunit 12-like protein isoform X7
mediator of RNA polymerase II transcription subunit 12-like protein isoform X2
mediator of RNA polymerase II transcription subunit 12-like protein isoform X4
mediator of RNA polymerase II transcription subunit 12-like protein isoform X1
mediator of RNA polymerase II transcription subunit 12-like protein isoform X3
purinergic receptor P2Y12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
purinergic receptor P2Y12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 7% coverage of the annotated genomic feature by RNAseq alignments
inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
glucose-dependent insulinotropic receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
thioredoxin reductase-like selenoprotein T
eukaryotic translation initiation factor 2A, transcript variant X1
eukaryotic translation initiation factor 2A, transcript variant X2
eukaryotic translation initiation factor 2A isoform X1
eukaryotic translation initiation factor 2A isoform X2
stress associated endoplasmic reticulum protein 1
stress-associated endoplasmic reticulum protein 1
TSC22 domain family member 2, transcript variant X2
TSC22 domain family member 2, transcript variant X1
TSC22 domain family protein 2 isoform X2
TSC22 domain family protein 2 isoform X1
ring finger protein 13, transcript variant X2
ring finger protein 13, transcript variant X1
ring finger protein 13, transcript variant X3
WW domain containing transcription regulator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WW domain-containing transcription regulator protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
transmembrane 4 L six family member 18, transcript variant X1
transmembrane 4 L six family member 18, transcript variant X2
transmembrane 4 L6 family member 18 isoform X1
transmembrane 4 L6 family member 18 isoform X2
HPS3 biogenesis of lysosomal organelles complex 2 subunit 1, transcript variant X2
HPS3 biogenesis of lysosomal organelles complex 2 subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 193 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns